Name | Price | Price Change | Analyst Price Target | Market Cap | Yearly Gain | Analyst Consensus | Smart Score | Follow |
---|---|---|---|---|---|---|---|---|
Gilead Sciences | $65.34 | $72.00 (10.19% Upside) | $81.90B | -5.63% | 4Buy 9Hold 0Sell Moderate Buy | premium | ||
Sorrento Therapeutics | $1.86 | $5.00 (168.82% Upside) | $723.44M | -79.17% | 1Buy 0Hold 0Sell Moderate Buy | premium | ||
Amgen | $250.86 | $242.69 (-3.26% Downside) | $134.19B | 15.95% | 4Buy 8Hold 2Sell Hold | premium | ||
AbbVie | $141.85 | $159.38 (12.36% Upside) | $250.80B | 24.28% | 7Buy 5Hold 1Sell Moderate Buy | premium | ||
GlaxoSmithKline | $34.06 | ― | $68.17B | -16.40% | 0Buy 0Hold 1Sell Moderate Sell | premium | ||
Eli Lilly & Co | $322.77 | $354.90 (9.95% Upside) | $306.69B | 20.82% | 10Buy 0Hold 0Sell Strong Buy | premium | ||
Regeneron | $618.36 | $669.69 (8.30% Upside) | $67.41B | -6.77% | 7Buy 8Hold 1Sell Moderate Buy | premium |